Rockwell Medical (RMTI)
(Real Time Quote from BATS)
$2.10 USD
+0.33 (18.64%)
Updated Aug 8, 2024 03:54 PM ET
After-Market: $2.10 0.00 (0.00%) 4:12 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$2.10 USD
+0.33 (18.64%)
Updated Aug 8, 2024 03:54 PM ET
After-Market: $2.10 0.00 (0.00%) 4:12 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Zacks News
Rockwell Medical (RMTI) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Rockwell Medical (RMTI) delivered earnings and revenue surprises of 20.00% and 0.05%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Rockwell Medical (RMTI) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Rockwell Medical (RMTI) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Rockwell Medical (RMTI) delivered earnings and revenue surprises of -12.50% and -9.59%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Rockwell Medical (RMTI) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Rockwell Medical (RMTI) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Rockwell Medical (RMTI) delivered earnings and revenue surprises of 16.67% and -7.94%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Rockwell Medical (RMTI) Q1 Earnings Expected to Decline
by Zacks Equity Research
Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights: Barclays, Rockwell Medical, NextEra, Belmond and Shaw Communications
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Barclays, Rockwell Medical, NextEra, Belmond and Shaw Communications
7 Hot Momentum Stocks to Watch in 2019
by Nabaparna Bhattacharya
These seven hot stocks appear quite promising for momentum-oriented investors, given their solid prospects to outperform the markets this year.
The Zacks Analyst Blog Highlights: Chimerix, MacroGenics, Rockwell Medical, TG Therapeutics and Valeritas
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Chimerix, MacroGenics, Rockwell Medical, TG Therapeutics and Valeritas
5 Beaten-Down Medical Product Stocks to Rebound in 2019
by Nabaparna Bhattacharya
As the Medical product industry is witnessing temporary sluggishness, a sneak peek into some possible outperformers in 2019 could be a great idea for investors.
Rockwell Medical (RMTI) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Rockwell Medical (RMTI) delivered earnings and revenue surprises of 33.33% and 11.15%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Rockwell Medical (RMTI) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Rockwell Medical (RMTI) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Rockwell Medical (RMTI) delivered earnings and revenue surprises of 15.38% and 0.09%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Implied Volatility Surging for Rockwell Medical (RMTI) Stock Options
by Zacks Equity Research
Rockwell Medical (RMTI) needs investors to pay close attention to the stock based on moves in the options market lately.
Rockwell Medical (RMTI) Catches Eye: Stock Moves Up 12.1%
by Zacks Equity Research
Rockwell Medical, Inc. (RMTI) moved big last session, as its shares rose over 12% on the day.
Rockwell Medical (RMTI) Looks Good: Stock Moves 5.9% Higher
by Zacks Equity Research
Rockwell Medical, Inc. (RMTI) shares rose almost 6% in the last trading session.
Implied Volatility Surging for Rockwell Medical (RMTI) Stock Options
by Zacks Equity Research
Investors in Rockwell Medical, Inc. (RMTI) need to pay close attention to the stock based on moves in the options market lately.
Implied Volatility Surging for Rockwell Medical (RMTI) Stock Options
by Zacks Equity Research
Investors in Rockwell Medical, Inc. (RMTI) need to pay close attention to the stock based on moves in the options market lately